Skip to main content
. 2014 Jul 3;17(2):150–158. doi: 10.1111/hpb.12290

Table 1.

Preoperative and operative characteristics of 303 patients undergoing liver resection for colorectal liver metastases

Value
Age, years, median (range) 67 (33–90)
Gender, n (%) Female 113 (37.3%)
Male 190 (62.7%)
T stage of primary, n (%) 0 3 (< 1%)
1 7 (2.3%)
2 19 (6.3%)
3 174 (57.4%)
4 91 (30.0%)
Unavailable 9 (3.0%)
N stage of primary, n (%) 0 133 (43.9%)
1 101 (33.3%)
2 64 (21.1%)
Unavailable 5 (1.7%)
Site of primary, n (%) Colonic 152 (50.2%)
Rectal 151 (49.8%)
Timing, n (%) Synchronous 144 (47.5%)
Metachronous 159 (52.5%)
Preoperative MRI, n (%) Yes 166 (54.8%)
No 137 (45.2%)
Preoperative PET, n (%) Yes 208 (68.6%)
No 95 (31.4%)
Preoperative liver-directed chemotherapy, n (%) Yes 151 (49.8%)
No 152 (50.2%)
Preoperative diabetes, n (%) Yes 28 (9.2%)
No 275 (90.8%)
BMI, kg/m2, median (range) 27 (16–54)
ASA class, n (%) 1 24 (7.9%)
2 211 (69.6%)
3 68 (22.4%)
Neutrophil : lymphocyte ratio, median (range) 2.58 (0.50–17.25)
Preoperative albumin, g/dl, median (range) 44 (26–52)
POSSUM physiological score, median (range) 16 (12–32)
Operation, n (%) Right hemihepatectomy 129 (42.6%)
Extended right 13 (4.3%)
Left hemihepatectomy 35 (11.6%)
Extended left 3 (1.0%)
Left lateral sectorectomy 31 (10.2%)
Wedge resection 79 (26.1%)
Other 13 (4.3%)
RFA included, n (%) Yes 19 (6.3%)
No 284 (93.7%)
Wedge resection included, n (%) Yes 122 (40.3%)
No 181 (59.7%)
Number of segments resected, median (range) 4 (1–6)
Repeat operation, n (%) Yes 33 (10.9%)
No 270 (89.1%)
Curative resection, n (%) Yes 284 (93.7%)
No 19 (6.3%)
Number of tumours, median (range) 1 (1–10)
Maximum tumour diameter, mm, median (range) 35 (3–155)
Resection margin, n (%) R0 232 (76.6%)
R1 71 (23.4%)

MRI, magnetic resonance imaging;

PET, positron emission tomography;

BMI, body mass index;

ASA, American Society of Anesthesiologists;

RFA, radiofrequency ablation.